Carla Gonçalves Schahin Saad

Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial

Ana Cristina de Medeiros Ribeiro, Nádia Emi Aikawa, Carla Gonçalves Schahin Saad et al. · Nature Medicine · 2021 · 214 citations

Vaccination, Rheumatology, Vaccine Safety +10

Abatacept and reduced immune response to pandemic 2009 influenza A/H1N1 vaccination in patients with rheumatoid arthritis

Ana Cristina de Medeiros Ribeiro, Iêda Maria Magalhães Laurindo, Lissiane Karine Noronha Guedes et al. · Arthritis Care & Research · 2012 · 109 citations

Immunogenicity and safety of the 2009 non-adjuvanted influenza A/H1N1 vaccine in a large cohort of autoimmune rheumatic diseases

Carla Gonçalves Schahin Saad, Eduardo Ferreira Borba, Nádia Emi Aikawa et al. · Annals of the Rheumatic Diseases · 2011 · 103 citations

Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice

Ana Cristina de Medeiros Ribeiro, Lissiane Karine Noronha Guedes, Júlio César Bertacini de Moraes et al. · Annals of the Rheumatic Diseases · 2011 · 96 citations

Glucocorticoid: Major Factor for Reduced Immunogenicity of 2009 Influenza A (H1N1) Vaccine in Patients with Juvenile Autoimmune Rheumatic Disease

Nádia Emi Aikawa, Lúcia Maria Arruda Campos, Clóvis A. Silva et al. · The Journal of Rheumatology · 2011 · 79 citations · Full text

Immunodeficiencies, Immunology, Flu Vaccination +23